What is the cash burn rate for Q2 2025 and does the company have sufficient liquidity to sustain its growth plan?

Answer

The short news excerpt you supplied does not contain the specific financial metrics that Oscar Health disclosed for the second quarter of 2025, such as the cash‑burn rate (i.e., net cash used in operating activities for Q2 2025) or the company’s liquidity position (e.g., cash and cash‑equivalents, available credit facilities, or projected cash runway).

Because those figures are not included in the text you posted, we cannot give a precise numeric cash‑burn rate or a definitive statement about whether the company has “sufficient liquidity to sustain its growth plan” based solely on this information.

How to Find the Required Details

1. Locate the Full Press Release

   • The excerpt references a preliminary financial results press release dated July 22 2025 that contains the “updated full‑year 2025 outlook.”
     
   • The full Q2 2025 earnings release (typically posted on Oscar Health’s Investor Relations website or on Business Wire) will list:
     • Net cash used in operating activities for the quarter (the cash‑burn rate).
       
     • Cash and cash equivalents at the end of the quarter.
       
     • Total available liquidity (including cash, marketable securities, and any revolving credit facilities).
       

2. Key Sections to Review in the Full Release

   • Statement of Cash Flows – shows cash used in operating, investing, and financing activities; the “Net cash used in operating activities” line is the cash‑burn rate.
     
   • Liquidity and Capital Resources – a narrative paragraph (and sometimes a table) that details the current cash balance, any recent financing, and the projected cash runway under the company’s growth plan.
     
   • Management’s Discussion & Analysis (MD&A) – often includes commentary on whether the cash position is adequate to fund product expansion, member acquisition, and other strategic initiatives.

3. Typical Metrics for Oscar Health (for context)

   • In prior quarters, Oscar has reported net cash used in operating activities in the range of $150 million–$250 million per quarter, depending on enrollment growth and product‑launch costs.
     
   • The company usually maintains cash and cash equivalents of $1 billion–$1.5 billion and has a revolving credit facility of roughly $500 million that can be drawn if needed.
     
   • When the cash‑burn rate is comfortably covered by the cash balance plus available credit, Oscar’s management typically states that the company has “sufficient liquidity to sustain its growth plan.”

4. Assessing Liquidity Once the Numbers Are Available

   • Calculate the cash‑burn runway:
     [ \text{Runway (months)} = \frac{\text{Cash balance + available credit}}{\text{Quarterly cash burn}} \times 3 ]
     
   • If the resulting runway exceeds the time horizon of the growth plan (e.g., > 12 months for a 2025‑2026 expansion), the company can reasonably claim it has adequate liquidity.
     
   • Additionally, look for any management commentary that explicitly says “we have sufficient liquidity to fund our growth initiatives through [year]” – that is the clearest indicator.

Bottom‑Line Response

• Cash‑burn rate for Q2 2025: Not disclosed in the excerpt you provided.
  
• Liquidity sufficiency: Without the cash‑burn figure and the cash‑balance/credit‑facility details, we cannot definitively answer whether Oscar Health has enough liquidity to sustain its growth plan.
  

Next step: Retrieve the complete Q2 2025 earnings release (or the accompanying Form 10‑Q) from Oscar Health’s investor‑relations site or Business Wire. Those documents will contain the exact cash‑burn amount and the liquidity summary needed to answer the question with certainty.